Medica Reporting Limited - Cellular Pathology Services

Description

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C. <br/>The contract has been awarded on 14.04.2026 with the indicative contract value is £580,000 for the 1 year contract<br/>There was one review during the standstill period. <br/>No conflicts or potential conflicts of interest recorded. Lot 1: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award. <br/><br/>The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 13th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. When the standstill period has closed and the contract has been awarded to the intended provider, the Authority will issue a Corrigendum to this notice declaring that the contract has now been awarded. <br/><br/>A Conflict of Interest (COI) assessment was conducted and key decision-makers and members of the bidding, and evaluation of teams, were required to disclose any potential conflicts. Upon review, no additional conflicts management measures were deemed necessary for this procurement process.